Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lívia Carneiro Matos"'
Autor:
Yasuyuki Yokosaki, Bianca F.P. Dias, Douglas V. Faget, Juliana S. P. Vasconcelos, Tatiana Martins Tilli, Lívia Carneiro Matos, E.R.P. Gimba, Eloisio Alexsandro da Silva
Publikováno v:
Oncology Letters. 2:109-114
Anti-tumor antibodies act as biomarkers for the early diagnosis of prostate cancer (PCa). Osteopontin (OPN) is overexpressed in PCa cells and contributes to the progression of the disease. This study aimed to evaluate whether OPN evokes a humoral imm
Autor:
Ludmilla Regina de Souza, Ricardo Bentes Azevedo, Paulo C. Morais, Zulmira Guerreiro Marques Lacava, Rosana Simón-Vázquez, África González-Fernández, E. Mosiniewicz-Szablewska, Piotr Suchocki, Alfredo Maurício Batista De-Paula, Sônia Nair Báo, Lívia Carneiro Matos, Luis Alexandre Muehlmann
Publikováno v:
Nanotechnology. 26(50)
Selol is a semi-synthetic compound containing selenite that is effective against cancerous cells and safer for clinical applications in comparison with other inorganic forms of selenite. Recently, we have developed a formulation of poly(methyl vinyl
Publikováno v:
Repositório Institucional da UnBUniversidade de BrasíliaUNB.
Tese (doutorado)—Universidade de Brasília, Faculdade de Medicina, Programa de Pós-Graduação em Patologia Molecular, 2013.
Submitted by Alaíde Gonçalves dos Santos (alaide@unb.br) on 2014-03-07T11:21:03Z No. of bitstreams: 1 2013_LiviaCar
Submitted by Alaíde Gonçalves dos Santos (alaide@unb.br) on 2014-03-07T11:21:03Z No. of bitstreams: 1 2013_LiviaCar
Externí odkaz:
http://repositorio.unb.br/handle/10482/15282
Autor:
C.H.C. Pessoa, D.B. Olmedo, I.M. Guerrero, Lívia Carneiro Matos, Tatiana Martins Tilli, Marcello A. Barcinski, E.R.P. Pontes, E.R.P. Gimba
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 16(1)
Mutations in different exons of ret proto-oncogene are responsible for the development of medullary thyroid carcinoma (MTC). The mutations can occur as sporadic or as part of multiple endocrine neoplasia (MEN) type 2 hereditary syndromes. Here we rep